Mankind Pharma, India’s fourth-largest pharmaceutical company, has announced the appointment of acclaimed actor Rajkummar Rao as the brand ambassador for its flagship pain relief brand, Nimulid Strong gel and spray.
This strategic partnership positions Nimulid Strong as the go-to “Neck Pain Specialist,” emphasizing its rapid action—delivering relief in just two minutes—and its powerful 2X diclofenac formulation. By aligning with Rao, known for his relatable persona and strong connection with everyday Indians, Mankind aims to reinforce the brand's commitment to helping people overcome pain and live more active, pain-free lives.
Rajkummar Rao, widely appreciated for his versatile acting and authenticity, perfectly complements Nimulid Strong’s core values of trust, efficacy, and empowerment. His mass appeal strengthens the brand’s positioning as a dependable solution for targeted pain relief.
India’s topical pain relief market is valued at over ₹5,000 crore, and Nimulid Strong is making its mark as a major player in this space. In its first year alone, the brand sold approximately 20 lakh units of gel and 10 lakh units of spray, generating ₹15 crore in revenue. Unlike many competing products that offer 1.16% diclofenac concentration, Nimulid Strong delivers a 2.32% formulation—offering deeper and more effective relief from pain and inflammation.
Joy Chatterjee, Vice President – Sales & Marketing, Consumer Business Unit, Mankind Pharma, stated:
“Rajkummar Rao’s credibility, relatability, and dedication to his craft make him an ideal representative for Nimulid Strong. His association strengthens our mission to support individuals in overcoming pain and discomfort swiftly, with reliable solutions like Nimulid Strong that work in just 2 minutes.”
Nimulid Strong is available in two convenient formats:
Nimulid Strong Gel: Designed for long-lasting, deep-penetrating relief.
Nimulid Strong Spray: Ideal for quick, on-the-go application—especially suited for active individuals.
Looking ahead, Mankind Pharma plans to expand the Nimulid Strong portfolio with innovative formats such as balms, roll-ons, and tablets, aiming to further disrupt and lead the topical pain relief category in India.